CBAL:CA:TSX-CI Balanced Asset Allocation ETF Common Units (CAD)

ETF | Others |

Last Closing

CAD 23.1

Change

-0.01 (-0.04)%

Market Cap

CAD 0.03B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.01 (-0.04%)

CAD 6.19B
XEQT:CA iShares Core Equity Portfolio

+0.08 (+0.24%)

CAD 6.03B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 5.57B
PHYS-U:CA Sprott Physical Gold Trust

+0.17 (+0.83%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.31 (+0.84%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.24 (+0.53%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.26 (+1.06%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.35 (+3.50%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.01%)

CAD 3.24B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.04 (+0.18%)

CAD 2.78B

ETFs Containing CBAL:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.26% 48% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.26% 48% F 43% F
Trailing 12 Months  
Capital Gain 11.70% 52% F 52% F
Dividend Return 1.69% 30% F 21% F
Total Return 13.39% 48% F 46% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.16% 62% D 51% F
Dividend Return 5.39% 61% D- 47% F
Total Return 0.23% 52% F 19% F
Risk Return Profile  
Volatility (Standard Deviation) 7.94% 62% D 81% B-
Risk Adjusted Return 67.89% 82% B 78% C+
Market Capitalization 0.03B 35% F 16% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.